What is Doximity's current Net Revenue Retention rate?

Doximity (DOCS) most recently reported a Net Revenue Retention of 112.0% for FY2026-Q3.

What is Doximity's all-time peak NRR?

Doximity's peak Net Revenue Retention was 173.0%, reported in FY2021-Q3.

How has Doximity's NRR changed over the past 3 years?

Over the past 3 years, Doximity's Net Revenue Retention has moved from 167.0% to 112.0% - a change of -55.0pp.

Where is Doximity's NRR data sourced from?

Every figure on this page is extracted from Doximity's SEC filings (10-Q, 10-K) and quarterly earnings press releases, then verified by a human reviewer against the original source. See cust.co/methodology/ for full details.

How does Doximity's NRR compare to its peers?

Doximity's most recent NRR (112.0%) is +0.0pp versus the median of 112% for Healthcare SaaS Public companies in the $25K-$100K ACV segment.

cust.co / Companies / Doximity (DOCS)

Doximity NRR

Name: Doximity Net Revenue Retention Time Series
Creator: Cust
License: https://cust.co/terms/

Net Revenue Retention history for Doximity (DOCS) - Healthcare SaaS, Public stage. Sourced from SEC filings and earnings releases.

Healthcare SaaS Public $25K-$100K ACV hybrid

Latest NRR · FY2026-Q3

112.0%

All-time peak

173.0%

FY2021-Q3

All-time low

112.0%

FY2026-Q3

Disclosures tracked

since FY2021-Q2

QoQ ▼ 6.0pp

YoY ▼ 2.0pp

3-year ▼ 55.0pp

NRR vs GRR over time

Gross Retention excludes expansion - it shows pure churn / contraction loss. The gap between NRR and GRR is the expansion lift.

Peak NRR of 173.0% in FY2021-Q3. Latest is 112.0% - that's -61.0pp from peak.

Doximity is above the Healthcare SaaS Public median by +0.0pp (cell median: 112%)

What the data shows

Doximity (DOCS) is a healthcare saas company at the public stage. As of its most recent disclosure (FY2026-Q3), Doximity reported a Net Revenue Retention rate of 112.0% - a mid-pack result for B2B SaaS at this segment.

Doximity's NRR peaked at 173.0% in FY2021-Q3, 61pp above today's level. Over the past three years, the metric has contracted by 55pp. The most recent quarter lost 6.0pp QoQ.

Within its peer set (healthcare saas companies at public stage in the $25k-$100k acv band), Doximity's NRR is roughly in line with the cell median of 112%. Compare against the full peer cell aggregate for distribution and top performers.

Get notified when Doximity next discloses

One email when DOCS's next quarterly NRR figure is verified. No spam, work email only, unsubscribe anytime.

We send roughly 1 email per quarter, only when verified data lands.

Embed this chart

Free to embed on your blog or board deck. Includes a small backlink to cust.co.

<iframe src="https://cust.co/companies/docs/embed/" width="600" height="400" frameborder="0"></iframe>

Or grab the data: JSON API

Every disclosure

Period	NRR	GRR	Source type	Filing
FY2026-Q3	112.0%	-	10-Q-mdna	source ↗
FY2026-Q2	118.0%	-	10-Q-mdna	source ↗
FY2026-Q1	118.0%	-	10-Q-mdna	source ↗
FY2025-Q3	117.0%	-	10-Q-mdna	source ↗
FY2025-Q2	114.0%	-	10-K	source ↗
FY2025-Q1	114.0%	-	10-Q-mdna	source ↗
FY2024-Q1	117.0%	-	10-K	source ↗
FY2023-Q1	153.0%	-	10-K	source ↗
FY-2022	119.0%	-	10-Q-mdna	source ↗
FY2022-Q4	133.0%	-	10-Q-mdna	source ↗
FY2022-Q3	128.0%	-	10-Q-mdna	source ↗
FY2022-Q2	139.0%	-	10-Q-mdna	source ↗
FY2022-Q1	139.0%	-	10-Q-mdna	source ↗
FY-2021	117.0%	-	10-Q-mdna	source ↗
FY2021-Q3	173.0%	-	10-Q-mdna	source ↗
FY2021-Q2	167.0%	-	10-Q-mdna	source ↗

Last verified disclosure: 2025-12-31 · Report an inaccuracy → · How we verify →